Multicenter Trial Evaluates BioMérieux's Vitek MS for Clinical Mold ID

Dec 06, 2017

Premium

NEW YORK (GenomeWeb) – A multi-center trial evaluating BioMérieux's Vitek MS clinical microbiology platform has found the MALDI mass spec-based system is able to identify molds commonly tested for in patients in clinical settings with high accuracy.

Using the instrument to test 1,601 mold isolates, researchers found that 98 percent of the identifications the system provided were correct, indicating the usefulness of the platform in clinical mycology.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Main menu